Literature DB >> 10325455

Lack of expression of interleukin 8 and RANTES in autoimmune bullous skin diseases.

E Bornscheuer1, D Zillikens, J M Schröder, M Sticherling.   

Abstract

BACKGROUND: In autoimmune bullous skin diseases, accumulation of neutrophils and/or eosinophils in the affected skin represents a characteristic feature. So far, however, the induction of this granulocyte infiltration has not been elucidated.
OBJECTIVE: Regarding their biological effects, the chemokines interleukin 8 (IL-8) and RANTES (regulated upon activation normal T lymphocyte expressed and secreted) could play a role in this granulocyte accumulation.
METHODS: Immunohistochemical examination of lesional skin from patients with bullous pemphigoid, pemphigus, dermatitis herpetiformis and linear IgA disease was performed using a set of different antibodies against IL-8 and RANTES. Additionally, blister fluids were screened for soluble RANTES peptide using an ELISA.
RESULTS: No difference in chemokine expression was found in lesions of autoimmune bullous diseases compared to normal skin.
CONCLUSION: In contrast to chronic inflammatory diseases like psoriasis and eczema, where keratinocyte IL-8 immunoreactivity was found to differ from normal skin, keratinocyte immunoreactivity is not altered in autoimmune bullous diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325455     DOI: 10.1159/000018085

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging.

Authors:  Jenny S Breitenbach; Mark Rinnerthaler; Andrea Trost; Manuela Weber; Alfred Klausegger; Christina Gruber; Daniela Bruckner; Herbert A Reitsamer; Johann W Bauer; Michael Breitenbach
Journal:  Aging (Albany NY)       Date:  2015-06       Impact factor: 5.682

2.  Cytokine and Chemokines Alterations in the Endemic Form of Pemphigus Foliaceus (Fogo Selvagem).

Authors:  Rodolfo Pessato Timóteo; Marcos Vinicius Silva; Djalma Alexandre Alves da Silva; Jonatas Da Silva Catarino; Fernando Henrique Canhoto Alves; Virmondes Rodrigues Júnior; Ana Maria Roselino; Helioswilton Sales-Campos; Carlo José Freire Oliveira
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.